Research Analysts Set Expectations for Tempest Therapeutics, Inc.s Q3 2024 Earnings - Defense World

TPST Stock  USD 0.97  0.11  10.19%   
Slightly above 51% of Tempest Therapeutics' private investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Tempest Therapeutics suggests that some traders are interested. Tempest Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Tempest Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
Research Analysts Set Expectations for Tempest Therapeutics, Inc.s Q3 2024 Earnings Defense World

Read at news.google.com
Google News at Macroaxis
  

Tempest Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Tempest Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Tempest Therapeutics Fundamental Analysis

We analyze Tempest Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tempest Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tempest Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Debt To Equity

Debt To Equity Comparative Analysis

Tempest Therapeutics is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Tempest Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tempest Therapeutics stock to make a market-neutral strategy. Peer analysis of Tempest Therapeutics could also be used in its relative valuation, which is a method of valuing Tempest Therapeutics by comparing valuation metrics with similar companies.

Peers

Tempest Therapeutics Related Equities

ZNTLZentalis Pharmaceuticals   5.66   
0%
89.0%
INDPIndaptus Therapeutics   2.61   
0%
41.0%
FBRXForte Biosciences   0.18   
2.0%
0%
OLMAOlema Pharmaceuticals   0.52   
8.0%
0%
RNXTRenovoRx   0.91   
14.0%
0%
ARMPArmata Pharmaceuticals   1.09   
17.0%
0%
IKNAIkena Oncology   1.14   
17.0%
0%
CGEMCullinan Oncology   1.44   
22.0%
0%
RVMDRevolution Medicines   2.02   
31.0%
0%
AKTXAkari Therapeutics   2.61   
41.0%
0%
PCSAProcessa Pharmaceuticals   2.73   
43.0%
0%
RZLTRezolute   3.09   
48.0%
0%
GLUEMonte Rosa   5.48   
86.0%
0%
LYELLyell Immunopharma   5.98   
94.0%
0%
ANEBAnebulo Pharmaceuticals   6.06   
95.0%
0%
SANASana Biotechnology   6.34   
100.0%
0%

Additional Tools for Tempest Stock Analysis

When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.